Drug Shortage Report for LANTUS
Report ID | 137925 |
Drug Identification Number | 02251930 |
Brand name | LANTUS |
Common or Proper name | Lantus |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | INSULIN GLARGINE |
Strength(s) | 100UNIT |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 5 |
ATC code | A10AE |
ATC description | INSULINS AND ANALOGUES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2021-05-12 |
Actual start date | |
Estimated end date | 2021-05-13 |
Actual end date | 2021-05-07 |
Shortage status | Avoided shortage |
Updated date | 2021-05-10 |
Company comments | A transportation delay may create a temporarily short term shortage. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Shortage could be avoided as allocation will be put in place. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-05-10 | French | Compare |
v3 | 2021-05-10 | English | Compare |
v2 | 2021-04-22 | French | Compare |
v1 | 2021-04-22 | English | Compare |
Showing 1 to 4 of 4